G-ROP Study Publications

  1. Binenbaum G, Tomlinson L, on behalf of the G-ROP Study Group: Postnatal Growth and Retinopathy of Prematurity Study: Rationale, Design, and Subject Characteristics. Ophthalm Epid 2017; 24(1): 36-47.

  2. Gurwin J, Tomlinson LA, Quinn GE, Ying GS, Baumritter A, Binenbaum G, on behalf of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group and the Telemedicine Approaches to Evaluating Acute-Phase Retinopathy of Prematurity (e-ROP) Cooperative Group: A Tiered Approach to Retinopathy of Prematurity Screening (TARP) Using a Weight Gain Predictive Model and a Telemedicine System. JAMA Ophthalmol. 2017;135(2):131–136.

  3. Binenbaum G, Ying GS, Tomlinson LA; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model. JAMA Ophthalmol. 2017;135(8):871-877.

  4. Binenbaum G, Bell EF, Donohue P, Quinn G, Shaffer J, Tomlinson LA, Ying GS; G-ROP Study Group. Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study. JAMA Ophthalmol. 2018;136(9):1034-1040.

  5. Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G; G-ROP Study Group. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018;136(12):1383-1389.

  6. Morrison D, Shaffer J, Ying GS, Binenbaum G; G-ROP Study Group. Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. J AAPOS. 2018;22(2):128-133.

  7. McCourt EA, Ying GS, Lynch AM, Palestine AG, Wagner BD, Wymore E, Tomlinson LA, Binenbaum G; G-ROP Study Group. Validation of the Colorado Retinopathy of Prematurity Screening Model. JAMA Ophthalmol. 2018;136(4):409-416.

  8. Bal S, Ying GS, Tomlinson L, Binenbaum G; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Association of Weight Gain Acceleration With Risk of Retinopathy of Prematurity. JAMA Ophthalmol. 2019;137(11):1301-1305.

  9. Liu T, Tomlinson LA, Ying GS, Yang MB, Binenbaum G; G-ROP Study Group. Treatment of non-type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study. J AAPOS. 2019;23(6):332.e1-332.e6.

  10. Ying GS, Bell EF, Donohue P, Tomlinson LA, Binenbaum G; G-ROP Research Group. Perinatal Risk Factors for the Retinopathy of Prematurity in Postnatal Growth and Rop Study. Ophthalmic Epidemiol. 2019;26(4):270-278.

  11. Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS; Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study Group. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmol. 2020;138(1):31-37.

  12. Zupancic JAF, Ying GS, de Alba Campomanes A, Tomlinson LA, Binenbaum G; G-ROP Study Group. Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) study. J Perinatol. 2020;40(7):1100-1108.

  13. Yu Y, Tomlinson LA, Binenbaum G, Ying GS; G-Rop Study Group. Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort. Br J Ophthalmol. 2020 Sep 26:bjophthalmol-2020-317467.

  14. Lin LY, Jensen AK, Quinn GE, Spiller A, Tomlinson LA, Ying GS, Binenbaum G. Symmetry of Disease in Retinopathy of Prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. Ophthalmic Epidemiol. 2020;27(6):477-481.

  15. Flannery DD, Jensen EA, Tomlinson LA, Yu Y, Ying GS, Binenbaum G; Postnatal Growth and ROP (G-ROP) Study Group. Poor postnatal weight growth is a late finding after sepsis in very preterm infants. Arch Dis Child Fetal Neonatal Ed. 2021;106(3):298-304.

  16. Barry GP, Yu Y, Ying GS, Tomlinson LA, Lajoie J, Fisher M, Binenbaum G; G-ROP Study Group. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmology. 2021;128(8):1188-1196.